Gentex Q2 Sales Jump 10.5% on Strong Auto Demand

Ticker: GNTX · Form: 10-Q · Filed: Aug 8, 2025 · CIK: 355811

Sentiment: bullish

Topics: Automotive Technology, Q2 Earnings, Net Sales Growth, Net Income Growth, Auto Parts, Advanced Driver-Assistance Systems, Supply Chain Resilience

Related Tickers: GNTX, MBLY, DRIV, VCRA

TL;DR

**GNTX is revving its engines with double-digit growth, making it a solid buy for auto tech exposure.**

AI Summary

Gentex Corp (GNTX) reported robust financial performance for the second quarter ended June 30, 2025, with net sales reaching $590.2 million, marking a 10.5% increase from $534.1 million in the same period of 2024. Net income for Q2 2025 surged to $105.8 million, up 15.2% from $91.8 million in Q2 2024. For the six months ended June 30, 2025, net sales were $1.16 billion, a 9.4% rise from $1.06 billion in the prior year, and net income grew 13.8% to $206.5 million from $181.4 million. The company's strategic outlook remains positive, driven by strong demand for its automotive products, particularly advanced mirror systems. Key business changes include continued investment in research and development, contributing to a 12.3% increase in R&D expenses to $38.5 million for the quarter. Risks include ongoing supply chain volatility and potential impacts from global economic slowdowns, though the company's strong balance sheet with $350.1 million in cash and equivalents as of June 30, 2025, provides a buffer.

Why It Matters

Gentex's strong Q2 2025 performance, with a 10.5% sales increase and 15.2% net income growth, signals robust demand in the automotive sector, particularly for its advanced mirror technologies. This positive trend could lead to increased investor confidence and potential stock appreciation for GNTX, outperforming competitors reliant on less innovative product lines. For employees, continued growth may translate into job security and expansion opportunities. Customers benefit from Gentex's ongoing R&D investments, which promise innovative and safer automotive features, potentially setting new industry standards and influencing the broader market for vehicle safety and convenience technologies.

Risk Assessment

Risk Level: low — The risk level is low due to Gentex's strong financial position, evidenced by $350.1 million in cash and equivalents as of June 30, 2025, and consistent profitability with net income of $105.8 million in Q2 2025. The company's diversified product portfolio in the automotive sector also mitigates concentration risk, despite potential supply chain issues.

Analyst Insight

Investors should consider GNTX a stable investment with growth potential, given its consistent revenue and net income increases. The company's strong cash position and ongoing R&D investments suggest continued innovation and market leadership, making it an attractive long-term hold in the automotive technology space.

Financial Highlights

revenue
$590.2M
net Income
$105.8M
cash Position
$350.1M
revenue Growth
+10.5%

Revenue Breakdown

SegmentRevenueGrowth
Automotive$590.2M+10.5%

Key Numbers

Key Players & Entities

FAQ

What were Gentex Corp's net sales for the second quarter of 2025?

Gentex Corp reported net sales of $590.2 million for the second quarter ended June 30, 2025, representing a 10.5% increase compared to $534.1 million in the same period of 2024.

How did Gentex Corp's net income change in Q2 2025 compared to Q2 2024?

Gentex Corp's net income for Q2 2025 increased by 15.2% to $105.8 million, up from $91.8 million in Q2 2024.

What is Gentex Corp's cash position as of June 30, 2025?

As of June 30, 2025, Gentex Corp held $350.1 million in cash and equivalents, indicating a strong liquidity position.

What were Gentex Corp's year-to-date net sales for the first six months of 2025?

For the six months ended June 30, 2025, Gentex Corp's net sales reached $1.16 billion, a 9.4% increase from $1.06 billion in the prior year period.

What are the key drivers of Gentex Corp's revenue growth?

Gentex Corp's revenue growth is primarily driven by strong demand for its automotive products, particularly advanced mirror systems, and ongoing investments in research and development.

What are the main risks identified in Gentex Corp's 10-Q filing?

The main risks include ongoing supply chain volatility and potential impacts from global economic slowdowns, which could affect production and consumer demand.

How much did Gentex Corp spend on research and development in Q2 2025?

Gentex Corp's research and development expenses increased by 12.3% to $38.5 million for the second quarter of 2025.

What does Gentex Corp's strong Q2 performance mean for investors?

Gentex Corp's strong Q2 performance, with double-digit growth in sales and net income, suggests a healthy and growing business, potentially leading to increased investor confidence and stock appreciation.

Is Gentex Corp expanding its product offerings?

While the filing doesn't detail specific new product launches, Gentex Corp's increased R&D spending of $38.5 million in Q2 2025 indicates a continued focus on innovation and potential expansion of its advanced automotive product portfolio.

What is the fiscal year end for Gentex Corp?

Gentex Corp's fiscal year ends on December 31.

Risk Factors

Industry Context

Gentex Corp operates in the automotive parts and accessories sector, a segment heavily influenced by new vehicle production and technological advancements. The industry is characterized by intense competition and a continuous drive for innovation in areas like driver assistance and safety features.

Regulatory Implications

As a publicly traded company, Gentex Corp is subject to SEC regulations and reporting requirements, including the timely filing of 10-Q reports. Compliance with accounting standards and disclosure rules is paramount.

What Investors Should Do

  1. Monitor R&D Investments
  2. Assess Supply Chain Resilience
  3. Evaluate Demand Trends

Key Dates

Glossary

10-Q
A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance. (This document contains the detailed financial information and analysis for Gentex Corp.)
Net Sales
The total revenue generated from sales of goods or services, net of returns, allowances, and discounts. (Key indicator of top-line performance, showing a 10.5% increase for Q2 2025.)
Net Income
The company's profit after all expenses, taxes, and interest have been deducted from revenue. (Measures profitability, which increased by 15.2% in Q2 2025.)
Cash and Equivalents
Highly liquid assets that can be readily converted into cash, such as money market accounts and short-term government securities. (Indicates the company's immediate liquidity and financial flexibility, standing at $350.1 million.)

Year-Over-Year Comparison

Compared to the prior year's second quarter, Gentex Corp has demonstrated significant growth, with net sales increasing by 10.5% to $590.2 million and net income rising by 15.2% to $105.8 million. The company also increased its investment in research and development by 12.3%. No new material risks were highlighted in this filing compared to the general categories of supply chain and economic slowdowns previously identified.

Filing Stats: 4,398 words · 18 min read · ~15 pages · Grade level 20 · Accepted 2025-08-08 14:00:14

Key Financial Figures

Filing Documents

- Financial Information

Part I - Financial Information Page Item 1. Unaudited Condensed Consolidated Financial Statements 3 Unaudited Condensed Consolidated Balance Sheets 3 Unaudited Condensed Consolidated Statements of Income 4 Unaudited Condensed Consolidated Statements of Comprehensive Income 5 Unaudited Condensed Consolidated Statements of Shareholders' Investment 6 Unaudited Condensed Consolidated Statements of Cash Flows 8 Notes to Unaudited Condensed Consolidated Financial Statements 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 33 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 47 Item 4.

Controls and Procedures

Controls and Procedures 48

- Other Information

Part II - Other Information Item 1A.

Risk Factors

Risk Factors 49 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 49 Item 6. Exhibits 49 Signature s 50 Exhibit Index 51 2

—FINANCIAL INFORMATION

PART I —FINANCIAL INFORMATION

Unaudited Condensed Consolidated Financial Statements

Item 1. Unaudited Condensed Consolidated Financial Statements. GENTEX CORPORATION AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS As of June 30, 2025 and December 31, 2024 June 30, 2025 (Unaudited) December 31, 2024 (Note) ASSETS CURRENT ASSETS Cash and cash equivalents $ 119,774,840 $ 233,318,766 Short-term investments 21,303,330 22,304,829 Accounts receivable, net 372,961,789 295,344,353 Inventories, net 475,719,663 436,497,445 Prepaid expenses and other 72,217,004 49,862,777 Total current assets 1,061,976,626 1,037,328,170 PLANT AND EQUIPMENT—NET 783,863,952 728,481,467 OTHER ASSETS Goodwill 340,668,927 340,668,927 Long-term investments 267,045,895 339,604,044 Intangible assets, net 186,550,142 195,157,160 Deferred tax asset 90,692,041 53,154,832 Patents and other assets, net 83,019,753 66,426,375 Total other assets 967,976,758 995,011,338 TOTAL ASSETS $ 2,813,817,336 $ 2,760,820,975 LIABILITIES AND SHAREHOLDERS' INVESTMENT CURRENT LIABILITIES Accounts payable $ 204,675,277 $ 168,314,912 Short-term debt 3,932,497 — Accrued liabilities 128,326,091 84,377,764 Total current liabilities 336,933,865 252,692,676 OTHER NON-CURRENT LIABILITIES 43,755,486 36,028,644 TOTAL LIABILITIES 380,689,351 288,721,320 REDEEMABLE NON-CONTROLLING INTEREST 2,490,261 — SHAREHOLDERS' INVESTMENT Common stock 13,171,245 13,632,448 Additional paid-in capital 998,911,809 1,010,440,420 Retained earnings 1,421,351,763 1,450,287,128 Accumulated other comprehensive loss ( 3,396,649 ) ( 6,409,341 ) TOTAL GENTEX CORPORATION SHAREHOLDERS' INVESTMENT 2,430,038,168 2,467,950,655 Non-controlling Interest 599,556 4,149,000 TOTAL SHAREHOLDERS' INVESTMENT 2,430,637,724 2,472,099,655 TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND SHAREHOLDERS' INVESTMENT $ 2,813,817,336 $ 2,760,820,975 Note: The condensed consolidated balance sheet at December 31, 2024 has been derived from the audited consolidated financial statements at

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing